Focused ultrasound
Focused Ultrasound is a therapeutic technology that uses ultrasound to target tissue deep in the body without incisions or radiation. It is an early-stage, non-invasive, therapeutic technology with the potential to improve the quality of life and decrease the cost of care for patients with a variety of medical conditions.
History
The concept of focused ultrasound was first proposed in the 1940s, but it was not until the late 20th century that significant advancements were made in the field. The development of Magnetic Resonance Imaging (MRI) in the 1970s and 1980s provided a means to monitor and control the treatment in real time, leading to the first FDA approval of a focused ultrasound device in 2004.
Technology
Focused ultrasound works by focusing multiple intersecting beams of ultrasound on a target. Each individual beam passes through tissue with little effect but at the focal point where the beams converge, the energy can have useful thermal or mechanical effects. This technology can be used to destroy tissue, such as tumors, or to stimulate the body's response to disease.
Applications
Focused ultrasound is currently approved in the United States for the treatment of uterine fibroids and bone metastases. It is also being investigated for the treatment of a variety of other conditions, including Parkinson's disease, Alzheimer's disease, and essential tremor.
Future
The future of focused ultrasound is promising, with ongoing research exploring new applications and improving the technology. The Focused Ultrasound Foundation, a global nonprofit dedicated to accelerating the development and adoption of focused ultrasound, is leading efforts to advance this field.
See also
- Ultrasound
- Magnetic Resonance Imaging
- Uterine fibroids
- Bone metastases
- Parkinson's disease
- Alzheimer's disease
- Essential tremor
This radiology related article is a stub. You can help WikiMD by expanding it.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
